FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, particularly to an ophthalmic product containing rebamipide characterised by sufficient transparency for tolerant sensations when applied, and a neutral to slightly acidic pH. An aqueous ophthalmic suspension of crystal rebamipide which has the improved transparency is prepared by adding aqueous rebamipide dissolved in a base, such as sodium hydroxide, or aqueous rebamipide salt in aqueous acid solution, such as hydrochloric acid, containing at least one of the compounds chosen from water-soluble polymers or surface-active substances, and by mixing said solutions.
EFFECT: invention allows not to damage keratoconjunctiva of the patient suffering from eye dryness.
12 cl, 9 tbl, 4 dwg, 16 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITIONS | 2009 |
|
RU2538694C2 |
| AQUEOUS PHARMACEUTICAL SUSPENSION CONTAINING REBAMIPIDE, AND METHOD FOR PREPARING IT | 2007 |
|
RU2467751C2 |
| METHODS OF OBTAINING ARIPIPRAZOLE SUSPENSION AND LYOPHILYSED COMPOSITION | 2008 |
|
RU2483711C2 |
| METHOD OF PREPARING AN AQUEOUS SUSPENSION AND AN AQUEOUS OPHTHALMIC PREPARATION | 1992 |
|
RU2098094C1 |
| EDARAVONE SUSPENSION FOR ORAL ADMINISTRATION | 2019 |
|
RU2810789C2 |
| CATALYST SUBSTRATE OF ALUMINIUM OXIDE | 2011 |
|
RU2566748C2 |
| ORAL PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF "DRY EYE" SYNDROME CONTAINING REBAMIPID OR ITS PRECURSOR | 2014 |
|
RU2632107C2 |
| AGENT FOR TREATING TUMOUR AND KIT CONTAINING LIPOSOMAL COMPOSITION OF GEMCITABINE | 2016 |
|
RU2768178C2 |
| PHARMACEUTICAL COMPOSITION OF CARBOXAMIDE INHIBITORS OF HIV INTEGRASE, CONTAINING COMPOSITION WITH CONTROLLED RATE OF RELEASE | 2005 |
|
RU2382648C2 |
| IRINOTECAN LIPOSOMES OR ITS SALTS, METHOD FOR PREPARING THEM | 2009 |
|
RU2526114C2 |
